411 related articles for article (PubMed ID: 26420636)
1. The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
Al Khalifah RA; Flórez ID; Dennis B; Neupane B; Thabane L; Bassilious E
Syst Rev; 2015 Sep; 4():125. PubMed ID: 26420636
[TBL] [Abstract][Full Text] [Related]
2. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
Al Khalifah RA; Florez ID; Dennis B; Thabane L; Bassilious E
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244814
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.
Domecq JP; Prutsky G; Mullan RJ; Sundaresh V; Wang AT; Erwin PJ; Welt C; Ehrmann D; Montori VM; Murad MH
J Clin Endocrinol Metab; 2013 Dec; 98(12):4646-54. PubMed ID: 24092830
[TBL] [Abstract][Full Text] [Related]
5. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
6. The treatment of polycystic ovary syndrome.
Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
[TBL] [Abstract][Full Text] [Related]
7. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
8. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
[TBL] [Abstract][Full Text] [Related]
10. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
12. SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Garcia-Beltran C; Malpique R; Andersen MS; Bas F; Bassols J; Darendeliler F; Díaz M; Dieris B; Fanelli F; Fröhlich-Reiterer E; Gambineri A; Glintborg D; López-Bermejo A; Mann C; Marin S; Obermayer-Pietsch B; Ødegård R; Ravn P; Reinehr T; Renzulli M; Salvador C; Singer V; Vanky E; Torres JV; Yildiz M; de Zegher F; Ibáñez L
Trials; 2023 Sep; 24(1):589. PubMed ID: 37715279
[TBL] [Abstract][Full Text] [Related]
13. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
Ibáñez L; de Zegher F
Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents.
Al Khalifah RA; Florez ID; Zoratti MJ; Dennis B; Thabane L; Bassilious E
J Endocr Soc; 2021 Jan; 5(1):bvaa155. PubMed ID: 33324861
[TBL] [Abstract][Full Text] [Related]
15. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
[TBL] [Abstract][Full Text] [Related]
16. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
Spritzer PM; Motta AB
Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of commonly used medical treatments for hirsutism in women.
Koulouri O; Conway GS
Clin Endocrinol (Oxf); 2008 May; 68(5):800-5. PubMed ID: 17980017
[TBL] [Abstract][Full Text] [Related]
18. Insulin-sensitizing agents in polycystic ovary syndrome.
Pasquali R; Gambineri A
Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
[TBL] [Abstract][Full Text] [Related]
19. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
20. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
